Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Saturn Oil & Gas Inc. Announces its First Development of Cardium Wells at Brazeau and Continued Successful Development (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News ImmuCell Corp ICCC

Healthcare Biotechnology
ImmuCell Corporation is an animal health company. The Company is engaged in the development, acquisition, manufacture, and sale of products that improve the health and productivity of dairy and beef cattle. It operates in two business segments: Scours and Mastitis. The Scours segment is engaged in manufacturing and selling First Defense, a product used to prevent scours in newborn calves, which... see more

Recent & Breaking News (NDAQ:ICCC)

ImmuCell Announces Sale of Certain Non-Core Assets

GlobeNewswire July 25, 2018

ImmuCell Announces Preliminary Sales Results for Second Quarter of 2018

GlobeNewswire July 10, 2018

ImmuCell to Join Russell Microcap Index

GlobeNewswire June 25, 2018

ImmuCell Announces Financial Results for First Quarter of 2018

GlobeNewswire May 14, 2018

ImmuCell Corporation to Host Earnings Call

Accesswire May 14, 2018

ImmuCell to Announce Financial Results for First Quarter of 2018

GlobeNewswire May 7, 2018

ImmuCell Announces Preliminary Financial Results for Fourth Quarter and Full Year 2017

GlobeNewswire February 8, 2018

ImmuCell Corporation to Host Earnings Call

Accesswire February 8, 2018

ImmuCell to Announce Financial Results for Fourth Quarter and Full Year 2017

GlobeNewswire February 5, 2018

ImmuCell Appoints Two New Members to its Board of Directors

GlobeNewswire January 30, 2018

ImmuCell Corporation Announces Closing of $3 Million Public Offering of Common Stock

GlobeNewswire December 21, 2017

Mid-Afternoon Market Update: NASDAQ Down 0.5%; China Recycling Energy Shares Spike Higher

Benzinga.com  December 19, 2017

36 Stocks Moving In Tuesday's Mid-Day Session

Benzinga.com  December 19, 2017

Mid-Morning Market Update: Markets Edge Lower; Darden Restaurants Tops Q2 Expectations

Benzinga.com  December 19, 2017

ImmuCell Corporation Announces Pricing of $3 Million Public Offering of Common Shares

GlobeNewswire December 19, 2017

ImmuCell Announces Financial Results for Third Quarter of 2017

GlobeNewswire November 13, 2017

ImmuCell Achieves USDA Approval of New Product Claim to Prevent Rotavirus Infections

GlobeNewswire November 13, 2017

ImmuCell Announces Completion of Construction of Nisin Production Facility

GlobeNewswire November 7, 2017

ImmuCell to Announce Financial Results for Third Quarter of 2017

GlobeNewswire November 2, 2017

ImmuCell Announces Expansion of Sales and Marketing Team

GlobeNewswire September 13, 2017